InnoTherapy Obtains Patent Rights for Stabilization Related to Adeno-Associated Virus

[Asia Economy Reporter Oh Ju-yeon] InnoTherapy announced on the 14th that it has obtained a domestic patent for a stabilizer for adeno-associated virus and a method for stabilizing adeno-associated virus using the same.

The company stated, "Adeno-associated virus, which is attracting attention as an efficient delivery vehicle for gene therapy, has excellent safety but faces stability limitations due to excessive aggregation during the manufacturing process. This technology can maintain adeno-associated virus particles in a state effective for drug delivery, thereby enhancing stability. We plan to utilize it in gene therapy development and drug delivery technology."